Clareon Vivity is the first and only non-diffractive extended depth of focus (EDOF) IOL with the wavefront-shaping X-WAVE Technology on Alcon’s most advanced lens platform1-6 Clareon Vivity joins ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

Please provide your email address to receive an email when new articles are posted on . MILAN — In difficult eyes or eyes with comorbidities in which diffractive trifocal IOLs are not an option, the ...

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof ® IQ Vivity ® and Clareon ® Vivity ...

Please provide your email address to receive an email when new articles are posted on . Last month, we started a conversation about extended focus IOLs and what makes a patient a good or bad candidate ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity ®, the most widely implanted 9 extended ...

Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) technology, has received CE Mark approval. The lens, made from Alcon's advanced ...

†Compared to CENTURION and CONSTELLATION Vision Systems. Based on bench data. **Based on worldwide unit sales of AcrySof® IQ Vivity and Clareon Vivity IOLs, as of Q4, 2024. “As ophthalmic practices ...